Navigation Links
Experts Report that Abbott's New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense
Date:11/1/2011

MUNICH, Nov. 2, 2011 /PRNewswire/ -- Abbott's PLEX-ID system provides reliable and rapid results for key microbial biothreat agents and should be considered as a first line analytical tool for biodefense, biosecurity and microbial forensics programs, according to research presented at the 13th Medical Biodefense Conference in Munich.  The meeting is a global congress for civilian and military researchers covering the latest developments in the diagnosis, therapy and prevention of diseases caused by dangerous pathogens.

"An essential component for robust defense against bioterrorism is to develop rapid microbial forensic diagnostic capabilities so threats can be identified with prompt and appropriate actions taken in response," said Bruce Budowle, Ph.D., professor, forensic and investigative genetics, University of North Texas Health Sciences Center, speaking at a symposium sponsored by the German Society for Military Medicine and Pharmacy.  "The PLEX-ID is a versatile instrument system and when coupled with the Biothreat Assay showed broad detection capability for a wide range of deadly and crippling microbes that could be used in a bioterrorism attack."

The PLEX-ID Biothreat Assay rapidly identifies 17 different biothreat pathogens without the need for time consuming culture testing.  A variety of specimens including blood, food, water, and air filter samples can be analyzed, and definitive results can be generated in less than eight hours.

Carson D. Baldwin, Ph.D., research chemist, U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID), presented results of an evaluation of the PLEX-ID Biothreat Assay in which several different panels of specimens were analyzed utilizing the Biothreat Assay.  The specimens contained pathogenic bacteria and viruses that could be used by terrorists to cause anthrax, cholera, and other diseases.  In the evaluation, PLEX-ID correctly detected and identified all the targeted bacteria and viruses including several important subspecies.

Rapid identification and characterization of potential biothreat agents is critical and was cited by speakers at the Medical Biodefense Conference as an attribute of the PLEX-ID system.

About PLEX-ID

The PLEX-ID system combines the sensitivity of nucleic acid amplification with the accuracy of high-performance electrospray ionization mass spectrometry followed by base-composition analysis to identify a broad array of microorganisms, including bacteria, viruses, fungi, and parasites.  Certain PLEX-ID assays also provide information about drug resistance, virulence, and strain type.  Anticipated public health and biodefense applications include epidemiologic research and identification of emerging or previously unknown agents. In addition, the system is being used for forensic characterization of human samples. In 2009, PLEX-ID was recognized by both The Scientist and the Wall Street Journal as a top scientific innovation of the year. Since its development in 2005, PLEX-ID technology has been deployed in sites around the United States, including the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration.

About Abbott  

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs nearly 90,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Hosts Technical Exchange for Industry Research Experts
2. Experts in Eye Care and Aging Call for Renewed Efforts in Glaucoma Detection and Management Among Americans
3. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
4. PRA Experts to Speak at Drug Safety Conference Breakout Session on Risk Management Strategies
5. Cancer Treatment Experts from Across Latin America Gather in Rio de Janeiro to Discuss Advances in Radiation Oncology
6. Renowned Experts to Share Early Insights Into Why Bariatric Surgery Improves Type 2 Diabetes for Many Patients
7. Texas & U.S. Drug Treatment Gap to Be Highlighted at News Conference 11 a.m. June 23 By Former U.S. Drug Czar, U.S. Music Industry/Grammys Addiction Services Leader, Miss Texas 2007, San Antonio Police Chief, Nations Leading Treatment CEO, Experts
8. PharmaNet Experts to Showcase Bioanalytical Posters at ASMS 2011
9. UBM Canons Pharmalot Brings Together a Virtual Panel of Experts to Discuss the Procurement Experience
10. Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
11. PRA International Experts to Speak at Drug Safety Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):